Importer of Controlled Substances; Notice of Application, 17472-17473 [05-6786]
Download as PDF
<![CDATA[
17472
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
Delaware renamed the road where the
facility is located, thus causing the
address to change. The address should
be modified to read: Dade Behring Inc.,
100 GBC Drive MS514, Post Office Box
6101, Attention: RA/QS, Newark,
Delaware 19714–6101.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6789 Filed 4–5–05; 8:45 am]
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6790 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By notice dated November 8, 2004,
and published in the Federal Register
on November 22, 2004 (69 FR 67963),
ISP Freetown Fine Chemicals, 238
South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in Schedule II.
The company plans to import
Phenylacetone to be used in the
manufacture of amphetamine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
ISP Freetown Fine Chemicals to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated ISP Freetown Fine
Chemicals to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
By notice dated February 17, 2005,
and published in the Federal Register
on February 28, 2005 (70 FR 9677–
9678), JFC Technologies, LLC, 100 West
Main Street, PO Box 669, Bound Brook,
New Jersey 08805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Meperidine-Intermediate
B (9233), a basic class of controlled
substance listed in Schedule II.
The company plans to import the
listed controlled substances for
manufacture of controlled substances in
bulk for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies, LLC to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated JFC
Technologies, LLC to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6798 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
VerDate jul<14>2003
18:17 Apr 05, 2005
Jkt 205001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Correction
The Notice dated December 21, 2004,
and published in the Federal Register
on January 4, 2005, (70 FR 393), the
drug code for Fentanyl was incorrect,
for Organichem Corporation, 33
Riverside Avenue, Rensselaer, New
York 12144. The correct drug code for
Fentanyl is (9801). The Notice of
Application should be corrected to
reflect Fentanyl (9801).
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6793 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a registration under 21 U.S.C.
952 (a) (2) (B) authorizing the
importation of such a substance,
provide manufacturers holding
registrations for the bulk manufacture of
the substance an opportunity for a
hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
February 1, 2005, Penick Corporation,
158 Mount Olivet Avenue, Newark,
New Jersey 07114, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
Schedules II:
Drug
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances to
manufacturer bulk controlled
substances and non-controlled
substance flavor extracts.
Any manufacturer who is presently,
or is applying to be, registered with DEA
E:\FR\FM\06APN1.SGM
06APN1
17473
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than May 6, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6786 Filed 4–5–05; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 8,
2005, Polaroid Corporation, 1265 Main
Street, Building W6, Waltham,
Massachusetts 02454, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of 2,5Dimethoxyamphetamine (7396), a basic
class of controlled substance listed in
Schedule I.
18:17 Apr 05, 2005
Jkt 205001
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6799 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Correction
By notice dated February 23, 2005,
and published in the Federal Register
on March 4, 2005 (70 FR 10683), the
listing of controlled substances
Oxycodone (9143) and Morphine (9300),
were inadvertently omitted, for
Siegfried (USA), Inc., Industrial Park
Road, Pennsville, New Jersey 08070.
The Notice of Application should be
corrected to include Oxycodone (9143)
and Morphine (9300).
BILLING CODE 4410–09–P
VerDate jul<14>2003
The company plans to manufacture
the listed controlled substance in bulk
for conversion into non-controlled
substances.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than June 6, 2005.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6791 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on January
7, 2005, Sigma Aldrich Company,
Subsidiary of Sigma-Aldrich
Corporation, 3500 Dekalb Street, St.
Louis, Missouri 63118, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
Schedule I and II:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Mescaline (7381) ..........................
4-Bromo-2,5-dimethoxy-amphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Psilocyn (7438) .............................
Benzylpiperazine (BZP) (7493) ....
1-(alpha, alpha, alpha-trifluoro-mtolyl)
Piperazine
(TEMPP)
(7494).
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
E:\FR\FM\06APN1.SGM
06APN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Pages 17472-17473]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6786]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
registration under 21 U.S.C. 952 (a) (2) (B) authorizing the
importation of such a substance, provide manufacturers holding
registrations for the bulk manufacture of the substance an opportunity
for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on February 1, 2005, Penick Corporation, 158 Mount Olivet Avenue,
Newark, New Jersey 07114, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed in Schedules II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Raw Opium (9600)........................... II
Poppy Straw (9650)......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacturer bulk controlled substances and non-controlled substance
flavor extracts.
Any manufacturer who is presently, or is applying to be, registered
with DEA
[[Page 17473]]
to manufacture such basic classes of controlled substances may file
comments or objections to the issuance of the proposed registration and
may, at the same time, file a written request for a hearing on such
application pursuant to 21 CFR 1301.43 and in such form as prescribed
by 21 CFR 1316.47.
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than May 6, 2005.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e) and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745-46), all applicants for
registration to import a basic class of any controlled substance listed
in Schedule I or II are, and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6786 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P
